Chronic liver disease (CLD) is associated with approximately two million annual deaths
worldwide and is an enormous health burden.[1, 2] The majority of liver-related outcomes …

Conclusions: While imaging-based noninvasive liver disease assessment appeared to have
higher accuracy than blood-based tests to detect CSPH, only 9 studies fit the a priori …

Abbreviations: ALD, alcohol-associated liver disease; APRI, aspartate aminotransferase–
platelet ratio index; ARFI, acoustic radiation force impulse; AUROC, area under the receiver …

Regardless of the underlying etiology and success of PE, progressive liver fibrosis and
eventually cirrhosis represent the dominant pathology and the end-stage of BA. Ascending …

Quantitative MRI Biomarkers of the Liver Sirlin and Reeder shear waves in the body, a
motion-encoding MRI sequence to depict the shear waves, and a so-called inversion …

This pilot study investigated the feasibility of using magnetic resonance elastography (MRE)
for the non-invasive detection and quantification of liver fibrosis in the Oncopig cancer …

Background and Aims A noteworthy proportion of patients with metabolic dysfunction–
associated steatotic liver disease (MASLD) have an indeterminate vibration-controlled …

Objectives To explore the impact of hepatic steatosis measured by MRI-proton density fat
fraction (MRI-PDFF) on liver stiffness measurement (LSM) value and its diagnostic …

The precise assessment of liver fibrosis degree is imperative for monitoring and managing
chronic liver diseases. Traditionally, liver biopsy and quantitative blood biomarkers have …

Highlights From the Recent AASLD Practice Guidelines on Noninvasive Assessment of
Hepatic Fibrosis and Steatosis - PMC Skip to main content Here's how you know Official …